Skip to Content

Ciclesonide Pregnancy and Breastfeeding Warnings

Ciclesonide is also known as: Alvesco

Medically reviewed by Drugs.com. Last updated on Jun 28, 2019.

Ciclesonide Pregnancy Warnings

Use is not recommended unless the benefit outweighs the risk to the fetus

AU TGA pregnancy category: B3
US FDA pregnancy category: C

Comments:
-Asthma should be closely monitored and medication adjusted as necessary to maintain optimal asthma control in pregnant women.
-Infants exposed to corticosteroids in utero should be observed for signs and symptoms of hypoadrenalism.

See references

Ciclesonide Breastfeeding Warnings

Benefit should outweigh risk

Excreted into human milk: Unknown
Excreted into animal milk: Yes

Comment: Inhaled corticosteroids are generally considered acceptable to use during breastfeeding as the amount, if excreted into breastmilk, would probably be too small to affect a breastfed infant.

See references

References for pregnancy information

  1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  2. Cerner Multum, Inc. "Australian Product Information." O 0
  3. "Product Information. Alvesco (ciclesonide)." Nycomed USA, Florham Park, NJ.

References for breastfeeding information

  1. "Product Information. Alvesco (ciclesonide)." Nycomed USA, Florham Park, NJ.
  2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  3. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT." ([cited 2013 -]):
  4. Cerner Multum, Inc. "Australian Product Information." O 0

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide